BioSentinel Pharmaceuticals

0 followers


BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).

Employees

1-10

Links

Org chart

Füsûn N. Zeytin
President & CEO

Füsûn N. Zeytin

Collapse
Julissa Salamanca
Executive Administrative Assistant
Ward Tucker
Director Of Research And Development
Mark Dunning
Director Of Molecular Biology

Teams

This company has no teams yet